Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Ryali becomes CFO of Codexis

Plus: Levisetti made CMO at Cue, and updates from Qu and Biocrucible

January 23, 2023 11:10 PM UTC

Enzyme engineering company  Codexis Inc. (NASDAQ:CDXS) hired Sri Ryali as CFO. Ryali was CFO at Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR), and before that, VP of finance at Aimmune Therapeutics Inc.

Cue Biopharma Inc. (NASDAQ:CUE) promoted SVP of Clinical Development Matteo Levisetti to CMO, succeeding acting CMO Kenneth Pienta, who will become a clinical adviser to the company. Levisetti was CMO at DNAtrix Inc. before joining Cue, which is developing biologics to activate T cells using its Immuno-STAT platform, in 2021...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article